News & Events

Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending

Cloud Adoption Can Prove Vital in Combating Cyberattacks

12th July 2021 – Written by Steve Holloway – Featured on AuntMinnie Europe – In the wake of the disruption to health services (HSE) in Ireland caused by cyberattacks in May, healthcare providers are looking at how cloud deployment can increase system protection, virtual attendees at the UK Imaging and Oncology (UKIO) Congress heart during […]

Post-COVID Telehealth in Europe: What Works for Primary Care? – Analysis

17th June 2021 – Written by Alex Green – Featured on HIT Consultant – The European primary care telehealth market has been transformed since the outbreak of COVID-19 more than 15 months ago. But which countries have developed an ecosystem that is primed for long-term growth that will bring value and improved processes to both healthcare providers and […]

The mobile C-arm is on the move

18th June 2021 – Written by Graham Cooke – Featured on DOTMed – Turner Imaging Systems has ambitious growth plans to expland across Europe, enabled by the confirmation of the CE mark for the Smart -C-Arm, adding to the FDA approval received in 2019. This is another step forward in the adoption of truly portable […]

Irish Cyberattack Provides wake-up Call for European Imaging IT

25th  May 2021 – Written by Steve Holloway – Featured on AuntMinnie Europe – The importance of cybersecurity for healthcare was brought sharply into focus again last week when the Irish healthcare system was crippled by a ransomware attach. At the time of writing on the 24th May, the fallout from the attack continued to […]

Assessing the oncology IT impact of the Siemens-Varian acquisition

19th May 2021 – Written by Imogen Fitt – Featured on Healthcare Business News – Siemens Healthineers officially completed the acquisition of Varian Medical Systems on April 15, 2021. The two companies constitute a combined annual revenue of around $20 billion, and there’s little doubt that this decision will have raised eyebrows amongst competitors in the oncology […]